amphetamine aspartate 12.5 MG / amphetamine sulfate 12.5 MG / dextroamphetamine saccharate 12.5 MG / dextroamphetamine sulfate 12.5 MG [Mydayis]
RxNorm concept 1927612, branded drug component (sbdc).
- RxCUI
- 1927612
- Term type
- Branded drug component (SBDC)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1927612 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- 3-Bead 24 HR amphetamine aspartate 12.5 MG / amphetamine sulfate 12.5 MG / dextroamphetamine saccharate 12.5 MG / dextroamphetamine sulfate 12.5 MG Extended Release Oral Capsule [Mydayis] (SBD, constitutes)
- Mydayis (BN, has ingredient)
- amphetamine aspartate 12.5 MG (SCDC, tradename of)
- amphetamine sulfate 12.5 MG (SCDC, tradename of)
- dextroamphetamine saccharate 12.5 MG (SCDC, tradename of)
- dextroamphetamine sulfate 12.5 MG (SCDC, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1927612 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1927612 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1927612. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.